Non-resolving long term Mucormycosis in Post-COVID-19 Patient: A Case Report
Nepalese Respiratory Journal · 2022
DOI: 10.3126/nrj.v1i2.54933 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nepalese Respiratory Journal, 2022. Verfasst von Sanjeet Bhattarai und 8 weiteren Autor:innen.
Abstract (Originalsprache)
With the second wave of COVID-19, there was a surge of cases of mucormycosis co-infection in our health center. We would like to present a case of a 53 years old man with COVID-19 positive status who later developed mucormycosis, with invasion of Maxillary sinus, jugular vein, digastric recess in MRI. He was managed with Amphotericin –B injection along with insulin therapy in sliding scale and Posaconazole thereafter for six months. Debridement of the lesion was done along with removal of inferior alveolar process of maxillary process and 3 molar teeth and a premolar tooth of upper left side.
Zitieren
APA
Bhattarai, S., Karthak, A., Gurung, N., Shrestha, A., Lama, R., Bhusal, Y., Giri, B., Chhetri, S., & Shrestha, S. K. (2022). Non-resolving long term Mucormycosis in Post-COVID-19 Patient: A Case Report. Nepalese Respiratory Journal. https://doi.org/10.3126/nrj.v1i2.54933
Vancouver
Bhattarai S, Karthak A, Gurung N, Shrestha A, Lama R, Bhusal Y, et al. Non-resolving long term Mucormycosis in Post-COVID-19 Patient: A Case Report. Nepalese Respiratory Journal. 2022. doi:10.3126/nrj.v1i2.54933
BibTeX
@article{Bhattarai2022,
author = {Bhattarai, Sanjeet and Karthak, Ashish and Gurung, Naresh and Shrestha, Ashish and Lama, Rakesh and Bhusal, Yuvaraj and Giri, Bijay and Chhetri, Sujan and Shrestha, Sanjeet Krishna},
title = {Non-resolving long term Mucormycosis in Post-COVID-19 Patient: A Case Report},
journal = {Nepalese Respiratory Journal},
year = {2022},
doi = {10.3126/nrj.v1i2.54933}
}
EUVIMED